VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
This Quarter Return
+40.5%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$47M
AUM Growth
+$47M
(-92%)
Cap. Flow
-$548M
Cap. Flow
% of AUM
-1,166.74%
Top 10 Holdings %
Top 10 Hldgs %
25.17%
Holding
310
New
6
Increased
35
Reduced
92
Closed
151
Top Buys
| 1 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$515K |
| 2 |
Franklin FTSE India ETF
FLIN
|
$355K |
| 3 |
Puma Biotechnology
PBYI
|
$276K |
| 4 |
ARRY
Array Biopharma Inc
ARRY
|
$255K |
| 5 |
Enanta Pharmaceuticals
ENTA
|
$238K |
Top Sells
| 1 |
MPLX
MPLX
|
$60.3M |
| 2 |
EQM
EQM Midstream Partners, LP
EQM
|
$58.3M |
| 3 |
Energy Transfer Partners
ET
|
$49.7M |
| 4 |
Enterprise Products Partners
EPD
|
$41.7M |
| 5 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
$30.5M |
Sector Composition
| 1 | Healthcare | 88.12% |
| 2 | Financials | 0.73% |
| 3 | Communication Services | 0.52% |
| 4 | Consumer Discretionary | 0.46% |
| 5 | Materials | 0.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TCDA
51
DELISTED
Tricida, Inc. Common Stock
TCDA
| $333K | 0.71% |
8,627
-1,006
| -10% | -$38.8K |
|
|
CBIO
52
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
| $331K | 0.7% |
266
-33
| -11% | -$41.1K |
|
53
Assertio
ASRT
$78M
| $326K | 0.69% |
16,079
-2,340
| -13% | -$47.4K |
|
54
Kura Oncology
KURA
$732M
| $323K | 0.69% |
19,441
-2,529
| -12% | -$42K |
|
|
AGEN
55
Agenus
AGEN
$136M
| $319K | 0.68% |
5,476
-679
| -11% | -$39.6K |
|
|
KDMN
56
DELISTED
Kadmon Holdings, Inc.
KDMN
| $317K | 0.67% |
119,987
-17,714
| -13% | -$46.8K |
|
57
Rocket Pharmaceuticals
RCKT
$358M
| $312K | 0.66% |
17,799
-1,805
| -9% | -$31.6K |
|
|
PRNB
58
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $308K | 0.66% |
9,048
-1,260
| -12% | -$42.9K |
|
59
Denali Therapeutics
DNLI
$2.24B
| $307K | 0.65% |
13,201
-1,589
| -11% | -$37K |
|
60
PTC Therapeutics
PTCT
$4.41B
| $299K | 0.64% |
7,947
-701
| -8% | -$26.4K |
|
61
Fate Therapeutics
FATE
$115M
| $292K | 0.62% |
16,612
-1,728
| -9% | -$30.4K |
|
62
Viking Therapeutics
VKTX
$3.02B
| $287K | 0.61% |
28,854
-3,457
| -11% | -$34.4K |
|
63
Corbus Pharmaceuticals
CRBP
$121M
| $282K | 0.6% |
1,354
-184
| -12% | -$38.3K |
|
64
Apellis Pharmaceuticals
APLS
$3.51B
| $280K | 0.6% |
14,338
-1,568
| -10% | -$30.6K |
|
65
Prothena Corp
PRTA
$452M
| $278K | 0.59% |
22,918
-2,964
| -11% | -$36K |
|
66
Akebia Therapeutics
AKBA
$827M
| $274K | 0.58% |
33,514
-4,669
| -12% | -$38.2K |
|
67
Cytokinetics
CYTK
$5.98B
| $273K | 0.58% |
33,758
-3,729
| -10% | -$30.2K |
|
|
XLRN
68
DELISTED
Acceleron Pharma Inc.
XLRN
| $271K | 0.58% |
5,810
-875
| -13% | -$40.8K |
|
|
ONC
69
BeOne Medicines Ltd. American Depositary Shares
ONC
$37B
| $269K | 0.57% |
2,041
-209
| -9% | -$27.5K |
|
|
AIMT
70
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $268K | 0.57% |
11,993
-1,694
| -12% | -$37.9K |
|
|
AUTL
71
Autolus Therapeutics
AUTL
$383M
| $265K | 0.56% |
8,434
-1,068
| -11% | -$33.6K |
|
|
ATNX
72
DELISTED
Athenex, Inc. Common Stock
ATNX
| $263K | 0.56% |
1,073
-152
| -12% | -$37.3K |
|
73
Marker Therapeutics
MRKR
$11.2M
| $262K | 0.56% |
3,967
-529
| -12% | -$34.9K |
|
74
Abeona Therapeutics
ABEO
$356M
| $261K | 0.56% |
1,419
-182
| -11% | -$33.5K |
|
75
Rhythm Pharmaceuticals
RYTM
$6.75B
| $260K | 0.55% |
9,468
-1,044
| -10% | -$28.7K |
|